文献速递心血管US

左心室整体纵向应变参考范围下限的预后相关性与验证:一项临床验证研究

Prognostic Relevance and Lower Limit of the Reference Range of Left Ventricular Global Longitudinal Strain: A Clinical Validation Study.
PubMed 文献 · JACC Cardiovasc Imaging · 2025-03-19

该研究通过Meta分析(47项研究、23,208名健康成人)及验证队列(2,217名健康成人)确定左心室整体纵向应变(GLS)的参考范围下限为16%(绝对值),并在≥80岁老年人及无症状心衰风险患者中验证GLS<16%与心衰住院显著相关(OR分别为3.1和5.1)。

要点

  • Meta分析(47项研究、23,208名健康成人)确定GLS参考范围下限为16%(绝对值),适用于EchoPac、TomTec和QLab等软件。
  • 验证队列(2,217名健康成人)同样识别GLS 16%为参考范围下限。
  • 无症状心衰风险患者(n=667)中GLS<16%与6年内心衰住院显著相关(OR 5.1,95%CI 1.5-17.0)。

核心结论

  • 该临床验证研究确定并验证GLS的参考范围下限为16%(绝对值),并显示GLS<16%在老年人和无症状心衰风险患者中具有预后相关性。

研究设计与样本

  • 研究包括一项Meta分析(47项研究、23,208名健康成人)以确定GLS参考范围下限,随后在2,217名健康成人中进行验证;另开展2项验证队列研究评估预后相关性,分别纳入≥80岁老年人(n=159)和左心室射血分数保留的无症状心衰风险门诊患者(n=667),使用二维斑点追踪经胸超声心动图。

诊断标准与关键数值

  • Meta分析(47项研究、23,208名健康成人)确定GLS参考范围下限为16%(绝对值),涵盖EchoPac、TomTec和QLab等软件;验证队列(2,217名健康成人)同样识别16%为参考范围下限;无症状心衰风险患者(n=667)中GLS<16%与6年内心衰住院相关(OR 5.1,95%CI 1.5-17.0);≥80岁老年人(n=159)中GLS<16%与2年内心衰住院相关(OR 3.1,95%CI 1.1-8.8)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The lower limit of the reference normal range (LLN) of left ventricular global longitudinal strain (GLS) for each ultrasound software vendor and its prognostic relevance in the elderly and in asymptomatic patients at risk for heart failure (HF) remain uncertain.

OBJECTIVES: In this study, the authors sought to validate the LLN of GLS for each ultrasound software vendor and its prognostic relevance in the elderly and in asymptomatic patients at risk for HF.

METHODS: To identify the LLN of GLS with the use of 2-dimensional speckle-tracking transthoracic echocardiography, a meta-analysis of studies including healthy subjects was conducted, followed by a validation study in a large cohort of healthy subjects. To validate the prognostic relevance of the LLN of GLS, 2 validation cohort studies were carried out, including elderly subjects aged ≥80 years and asymptomatic ambulatory patients with preserved left ventricular ejection fraction at risk for HF.

RESULTS: The meta-analysis, which included 47 studies with a total of 23,208 healthy adult subjects, identified the LLN for GLS at 16% (absolute value) across various ultrasound software vendors, including EchoPac, TomTec, and QLab. In the validation cohort study, which included 2,217 healthy adult subjects, a GLS cutoff of 16% was also identified as the LLN. Concerning the prognostic relevance of the LLN of GLS, a value of GLS <16% was significantly associated with HF hospitalization in asymptomatic ambulatory patients at risk for HF (n = 667; OR within 6 years: 5.1 [95% CI: 1.5-17.0]) and in elderly subjects (n = 159; OR within 2 years: 3.1 [95% CI: 1.1-8.8]).

CONCLUSIONS: This clinical validation study provides important clinical data concerning the LLN of GLS (identified and validated at 16%) and its prognostic relevance in the elderly and in asymptomatic ambulatory patients at risk for HF.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Morris DA, Hung CL, Biering-Sørensen T, et al. Prognostic Relevance and Lower Limit of the Reference Range of Left Ventricular Global Longitudinal Strain: A Clinical Validation Study. JACC Cardiovasc Imaging. 2025. PMID: 40117395. doi:10.1016/j.jcmg.2024.11.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。